SEC Form D filing

Biologic Capital, Inc.

Biotech · Regulation D 506(b) · CA · Filed May 13, 2026

Offering amount
Undisclosed
Exemption
Reg D 506(b)
Issuer state
CA
Filing date
May 13, 2026
Signature date
CIK
0002134754

Summary

Biologic Capital name suggests biotech focus; no offering amount disclosed.

Source

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.